Movement Alert｜DaVita HealthCare Partners Falls 6.63% in Pre-Market Trading, Q3 Beat Overshadowed by Limited Guidance Increase

Market Focus10-30 20:27

On October 30, DaVita HealthCare Partners fell 6.63% in Pre-Market Trading, trading at $181.875 per share, with turnover of $173,700.

The move followed the company’s latest quarterly report: third-quarter adjusted EPS was $3.82, above the $3.57 to $3.61 market expectation, while revenue reached $3.58 billion, also ahead of the roughly $3.51 billion to $3.52 billion consensus. However, full-year adjusted EPS guidance was only raised to $14.30-$15.20 from $14.10-$15.20, with the upper end unchanged and the midpoint still close to expectations, limiting investor enthusiasm despite the earnings beat.

Additional disclosure showed DaVita HealthCare Partners repurchased 382,563 shares from Berkshire Hathaway. While that update may support capital return optics, the immediate price reaction appears primarily tied to the modest guidance lift after a stronger-than-expected quarter.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment